Organovo Holdings, Inc. (NASDAQ:ONVO) has received a consensus rating of “Hold” from the seven brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating and five have assigned a buy rating to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $6.00.

Several research firms have commented on ONVO. Jefferies Group LLC reissued a “buy” rating and set a $4.00 price target on shares of Organovo Holdings in a research note on Tuesday, September 26th. Zacks Investment Research raised shares of Organovo Holdings from a “hold” rating to a “buy” rating and set a $2.25 target price on the stock in a research note on Wednesday, October 11th. BidaskClub downgraded shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a research note on Tuesday, July 25th. Finally, ValuEngine downgraded shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a research note on Friday, September 1st.

TRADEMARK VIOLATION WARNING: “Organovo Holdings, Inc. (ONVO) Receives Consensus Recommendation of “Hold” from Analysts” was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/11/02/organovo-holdings-inc-onvo-receives-consensus-recommendation-of-hold-from-analysts.html.

Organovo Holdings (NASDAQ:ONVO) last posted its quarterly earnings results on Wednesday, August 9th. The company reported ($0.10) EPS for the quarter, hitting the consensus estimate of ($0.10). The firm had revenue of $0.99 million for the quarter, compared to the consensus estimate of $0.92 million. Organovo Holdings had a negative net margin of 918.97% and a negative return on equity of 65.49%. The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Organovo Holdings by 8.5% in the first quarter. Vanguard Group Inc. now owns 4,250,017 shares of the company’s stock worth $13,515,000 after buying an additional 333,034 shares during the period. ARK Investment Management LLC boosted its holdings in Organovo Holdings by 134.5% in the second quarter. ARK Investment Management LLC now owns 1,445,039 shares of the company’s stock valued at $3,800,000 after acquiring an additional 828,787 shares in the last quarter. Metropolitan Life Insurance Co. NY boosted its holdings in Organovo Holdings by 15.0% in the first quarter. Metropolitan Life Insurance Co. NY now owns 68,487 shares of the company’s stock valued at $218,000 after acquiring an additional 8,958 shares in the last quarter. KCG Holdings Inc. boosted its holdings in Organovo Holdings by 139.3% in the first quarter. KCG Holdings Inc. now owns 144,501 shares of the company’s stock valued at $460,000 after acquiring an additional 84,126 shares in the last quarter. Finally, Nationwide Fund Advisors boosted its holdings in Organovo Holdings by 12.7% in the first quarter. Nationwide Fund Advisors now owns 60,565 shares of the company’s stock valued at $193,000 after acquiring an additional 6,802 shares in the last quarter. 23.93% of the stock is currently owned by institutional investors.

About Organovo Holdings

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.